Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM-SFC 2004 Guidelines in a population of diabetic patients;Étude de la faisabilité du dépistage de l'ischémie myocardique silencieuse selon les recommandations de l'ALFEDIAM-SFC de 2004

Diabetes and Metabolism

Volumn 36, Issue 4, 2010, Pages 286-292

  Hiebel, A ^a   Fagot Campagna, A ^b   Fosse, S ^b   Varroud Vial, M ^c   Weill, A ^d   Penfornis, A ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

^c CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^d Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

Author keywords

Cardiovascular risk factors; Diabetes; Recommendations; Screening; Silent myocardial ischaemia

Indexed keywords

DOBUTAMINE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG UTILIZATION; EXERCISE TEST; FRANCE; HEALTH CARE COST; HEART MUSCLE PERFUSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MYOCARDIAL PERFUSION IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREVALENCE; QUESTIONNAIRE; SCREENING TEST; SILENT MYOCARDIAL ISCHEMIA; STRESS ECHOCARDIOGRAPHY;

EID: 77956969561     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.01.011     Document Type: Article

References (29)

1. Kusnik-Joinville O., Weill A., Ricordeau P., Allemand H. Diabète traité en France en 2007: un taux de prévalence proche de 4 % et des disparités géographiques croissantes. BEH 2008, 43:409-413.
2. Kusnik-Joinville O., Weill A., Salanave B., Ricordeau P., Allemand H. Diabète traité: quelles évolutions entre 2000 et 2005 ?. Prat Organ Soins 2007, 1-12.
3. Cubbon R.M., Abbas A., Wheatcroft S.B., Kilcullen N., Das R., Morrell C. Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event. PLoS One 2008, 3:e3483.
4. Donahoe S.M., Stewart G.C., McCabe C.H., Mohanavelu S., Murphy S.A., Cannon C.P., et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007, 298:765-775.
5. Brindel P., Fagot-Campagna A., Petit C., Coliche V., Isnard H., Simon D., et al. Entred: lancement d'une étude sur un échantillon national de 10000 personnes diabétiques traitées. BEH 2002, 20-21:88-89.
6. Marant C., Romon I., Fosse S., Weill A., Simon D., Eschwège E., et al. French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes Metab 2008, 34:38-45.
7. Puel J., Valensi P., Vanzetto G., Lassmann-Vague V., Monin J.L., Moulin Ph, et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004, 30(3):S3-S18.
8. Passa P., Drouin P., Issa-Sayegh M., Blasco A., Masquet C., Monassier J.P., et al. Coronary disease and diabetes. Diabetes Metab 1995, 21:446-451.
9. Janand-Delenne B., Savin B., Habib G., Bory M., Vague P., Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999, 22:1396-1400.
10. Penfornis A., Zimmermann C., Boumal D., Sabbah A., Meneveau N., Gaultier-Bourgeois S., et al. Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 2001, 18:900-905.
11. Haute Autorité de santé. How to judge a proposal for a screening programme. Methodological guide. Paris: HAS; 2004.
12. Institut de Veille Sanitaire. [cited 9 October 2009]; available from: http://www.invs.sante.fr/entred/.
13. Detournay B., Vauzelle-Kervroedan F., Charles M.A., Forhan A., Fagnani F., Fender P., et al. Epidemiology, management and costs of type 2 diabetes in France in 1998. Diabetes Metab 1999, 25:356-365.
14. Ricordeau P., Weill A., Vallier N., Bourrel R., Fender P., Allemand H. Epidemiology of diabetes in metropolitan France. Diabetes Metab 2000, 26(Suppl 6):11-24.
15. Institut National de la Statistique et des Études Économiques. [cited 12 October 2009]; available from: http://www.insee.fr/.
16. Vanzetto G., Halimi S., Hammoud T., Fagret D., Benhamou P.Y., Cordonnier D., et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999, 22:19-26.
17. Meisinger C., Heier M., Landgraf R., Happich M., Wichmann H.E., Piehlmeier W. Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross-sectional study. BMC Health Serv Res 2008, 8:226.
18. Bax J.J., Young L.H., Frye R.L., Bonow R.O., Steinberg H.O., Barrett E.J. ADA. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007, 30:2729-2736.
19. Le Feuvre C.L., Barthelemy O., Dubois-Laforgue D., Maunoury C., Mogenet A., Baubion N., et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab 2005, 31:135-142.
20. Frye R.L., August P., Brooks M.M., Hardison R.M., Kelsey S.F., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2570-2572.
21. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
22. Wackers F.J., Chyun D.A., Young L.H., Heller G., Iskandrian A., Davey J., et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 2007, 30:2892-2898.
23. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D., Davey J., Barrett E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004, 27:1954-1961.
24. Young L.H., Wackers F.J., Chyun D.A., Davey J., Barrett E., Taillefer R., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009, 301:1547-1555.
25. Kronmal R.A., McClelland R.L., Detrano R., Shea S., Lima J.A., Cushman M., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007, 115:2722-2730.
26. Nair D., Carrigan T.P., Curtin R.J., Popovic Z.B., Kuzmiak S., Schoenhagen P., et al. Association of coronary atherosclerosis detected by multislice computed tomography and traditional risk-factor assessment. Am J Cardiol 2008, 102:316-320.
27. Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006, 47:65-71.
28. Fornengo P., Bosio A., Epifani G., Pallisco O., Mancuso A., Pascale C. Prevalence of silent myocardial ischaemia in new-onset middle-aged type 2 diabetic patients without other cardiovascular risk factors. Diabet Med 2006, 23:775-779.
29. Ricci P., Chantry M., Detournay B., Poutignat N., Kusnik-Joinville O., Raimond V., et al. Reimbursed health expenditures of people treated for diabetes by the French National Health Insurance Fund: 2001 and 2007 ENTRED Surveys. BEH 2009, 42-43:464-469.